Novo Holdings A/S is the holding and investment company wholly owned by the Novo Nordisk Foundation. Based in Hellerup, Denmark, it manages the Foundation’s assets and provides long-term ownership for the Novo Group. Novo Holdings is the controlling shareholder of Novo Nordisk A/S and a major shareholder in Novonesis (formed from the merger of Novozymes and Chr. Hansen).
The firm invests globally across the life sciences and industrial biosolutions value chain, from venture capital to growth equity and large-scale principal investments, alongside a diversified financial portfolio. Its focus spans biopharmaceuticals, industrial enzymes and biomanufacturing, research tools, medtech, and related enabling technologies—areas closely linked to innovation and sustainability in the chemical and materials sectors.